Human Technopole Commitment to Gender Equality
Human Technopole is proud to announce the launch of its new Gender Equality Plan (GEP) for 2025-2027, a strategic initiative designed to further integrate gender equality across all aspects of the Institute, building upon the successful outcomes of the previous GEP (2022-2024). HT has also achieved the UNI/PdR 125:2022 certification, which recognizes organizations that promote gender equality and foster inclusive workplaces.
HT’s mission is to improve human life and technology through cutting-edge basic research in the life sciences. With this new GEP, HT strengthens its commitment to creating a gender-inclusive environment, recognizing the importance of integrating gender perspectives in scientific research, training, and public health policies. By promoting gender equality, HT aims to foster an organizational culture of transparency, collaboration, and excellence.
The plan identifies six key objectives: raising awareness of gender equality and diversity, supporting work-life balance, ensuring gender balance in recruitment, mainstreaming gender in research, addressing gender-based violence, and improving communication of GEP actions.
The GEP is aligned with the European Union’s commitment to gender equality, a fundamental value enshrined in its foundational documents. It adheres to the EU’s strategic priorities and the European Institute for Gender Equality’s (EIGE) guidelines. This plan is part of HT’s broader efforts to contribute to a more inclusive and diverse research environment, ensuring fairness and equality in all its activities.
Share:
You could also like:
-
2 fully funded PhD fellowships at HT through SISSA
Human Technopole is offering 2 fully funded 4-year PhD fellowships to young scientists from the national and international community who wish to undertake a doctoral degree on a project focused on Computational Biology.
-
Childhood Cancer: Free DNA in Blood Reveals Therapy Resistance
An international study coordinated by Milan’s Human Technopole, the Institute of Cancer Research (ICR) in London, and the Royal Marsden Hospital in London has shown that certain DNA fragments found in the blood of paediatric cancer patients can be used as “biomarkers” to obtain information on the characteristics of the disease and its ability to resist therapies. Analysing these fragments could represent an effective alternative to tumour tissue biopsy, a practice that is particularly difficult in children.
-
Human Technopole at the Quirinale: Advancing Innovation with MIND
Human Technopole is honoured to have participated in today’s meeting at the Quirinale, where President of the Republic Sergio Mattarella welcomed a delegation from MIND on the occasion of the tenth anniversary of the universal exposition Milano EXPO 2015.
-
Exploring Nuclear Proteomics with the PRUNE Project
Meet Carlos Jimenez, Postdoc in the Bienko Group (Genomics), who has been awarded a prestigious Marie Skłodowska-Curie Actions Postdoctoral Fellowship from the European Union. The grant, totalling €172,750.08 and covering a two-year period, will support his groundbreaking project PRUNE – Uncovering the Proteomic Radial Organisation within the Eukaryotic Nucleus – to study how the spatial arrangement of nuclear proteins contributes to optimal cell functioning.
-
The “tubulin code” in control of molecular train logistics in cilia
By developing a sophisticated in vitro system coupled with advanced imaging techniques and CRISPR genome editing, an international team of researchers from Human Technopole (Italy) and the TUD Dresden University of Technology (Germany) shows that tubulin tyrosination/detyrosination regulates the bidirectional IFT train movement and avoids collision between trains moving in opposite directions along the cilium. The research was funded by the ERC and the DFG “Physics of Life” Excellence Cluster. The results are published in Nature Communications.